Sodium-lithium countertransport activity in normotensive offspring of hypertensive black Africans

A O Obasohan1, C O Osuji, I A Oforofuo

  • 1Department of Medicine, Uniben/UBTH, Benin City, Nigeria.

Insights

Elevated sodium-lithium countertransport (SLC) activity was observed in hypertensive Nigerians and their normotensive offspring, suggesting a familial predisposition to hypertension. This finding mirrors patterns seen in Caucasian populations.

Area of Science:

  • Cardiovascular Research
  • Human Genetics
  • Biochemistry

Background:

  • Hypertension is a significant global health concern with complex etiologies.
  • Familial predisposition plays a role in hypertension development.
  • Sodium-lithium countertransport (SLC) and erythrocyte sodium (ENa) are potential biomarkers for hypertension risk.

Purpose of the Study:

  • To investigate SLC activity and ENa levels in Nigerian hypertensive patients and their normotensive offspring.
  • To determine if elevated SLC activity is linked to a familial predisposition to hypertension in Black subjects, similar to findings in Caucasians.

Main Methods:

  • A study involving 60 Nigerian subjects of Edo ethnic origin, divided into three groups: untreated hypertensive patients, normotensive offspring of hypertensive parents, and normotensive offspring of normotensive parents.
  • SLC activity was measured using a modified Canessa et al. method.
  • Erythrocyte sodium (ENa) levels were assessed by flame photometry.

Main Results:

  • SLC activity was significantly higher in both hypertensive patients and normotensive offspring of hypertensive parents compared to normotensive offspring of normotensive parents.
  • No significant difference in SLC activity was found between hypertensive patients and their normotensive offspring.
  • Erythrocyte sodium (ENa) levels were elevated in hypertensive patients compared to both normotensive groups.

Conclusions:

  • Elevated SLC activity in normotensive offspring of hypertensive individuals suggests a genetic predisposition to hypertension in Black subjects.
  • The observed pattern of SLC activity in Black subjects is similar to that found in Caucasian populations.
  • SLC activity may serve as a valuable indicator of familial hypertension risk across different ethnic groups.
Abstract

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...